Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Open accessThe DOI matches its Crossref record; 273 of the 276 references it cites were found in a registry or an index.
Abstract
We describe a recently recognized disease entity, limbic-predominant age-related TDP-43 encephalopathy (LATE). LATE neuropathological change (LATE-NC) is defined by a stereotypical TDP-43 proteinopathy in older adults, with or without coexisting hippocampal sclerosis pathology. LATE-NC is a common TDP-43 proteinopathy, associated with an amnestic dementia syndrome that mimicked Alzheimer's-type dementia in retrospective autopsy studies. LATE is distinguished from frontotemporal lobar degeneration with TDP-43 pathology based on its epidemiology (LATE generally affects older subjects), and relatively restricted neuroanatomical distribution of TDP-43 proteinopathy. In community-based autopsy cohorts, ∼25% of brains had sufficient burden of LATE-NC to be associated with discernible cognitive impairment. Many subjects with LATE-NC have comorbid brain pathologies, often including amyloid-β plaques and tauopathy. Given that the 'oldest-old' are at greatest risk for LATE-NC, and subjects of advanced age constitute a rapidly growing demographic group in many countries, LATE has an expanding but under-recognized impact on public health. For these reasons, a working group was convened to develop diagnostic criteria for LATE, aiming both to stimulate research and to promote awareness of this pathway to dementia. We report consensus-based recommendations including guidelines for diagnosis and staging of LATE-NC. For routine autopsy workup of LATE-NC, an anatomically-based preliminary staging scheme is proposed with TDP-43 immunohistochemistry on tissue from three brain areas, reflecting a hierarchical pattern of brain involvement: amygdala, hippocampus, and middle frontal gyrus. LATE-NC appears to affect the medial temporal lobe structures preferentially, but other areas also are impacted. Neuroimaging studies demonstrated that subjects with LATE-NC also had atrophy in the medial temporal lobes, frontal cortex, and other brain regions. Genetic studies have thus far indicated five genes with risk alleles for LATE-NC: GRN, TMEM106B, ABCC9, KCNMB2, and APOE. The discovery of these genetic risk variants indicate that LATE shares pathogenetic mechanisms with both frontotemporal lobar degeneration and Alzheimer's disease, but also suggests disease-specific underlying mechanisms. Large gaps remain in our understanding of LATE. For advances in prevention, diagnosis, and treatment, there is an urgent need for research focused on LATE, including in vitro and animal models. An obstacle to clinical progress is lack of diagnostic tools, such as biofluid or neuroimaging biomarkers, for ante-mortem detection of LATE. Development of a disease biomarker would augment observational studies seeking to further define the risk factors, natural history, and clinical features of LATE, as well as eventual subject recruitment for targeted therapies in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Statistical analyses on data related to LATE from the Rush University community-based autopsy cohort depicting the results of pathway analyses. Data were analysed from research volunteers (total n = 1309) in two clinical‐pathological studies of ageing from Rush University as described previously (Power et al., 2018). In this sample, the mean age of death was 89.7 years [standard deviation (SD) 6.5 years, range 65–108 years]. These analyses incorporated age, density of amyloid-β neuritic amyloid plaques (to factor in ADNC), TDP-43 proteinopathy, hippocampal sclerosis pathology, and the endpoint of Alzheimer’s-type clinical dementia. The components of the pathway analyses most strongly associated with LATE-NC are shown in red. The numbers are path coefficients with standard error in parentheses (shown in purple). These numbers help to quantify the effects of individual pathways. For instance, the data are compatible with there being two pathways from TDP-43 proteinopathy to dementia, one direct pathway (TDP-43 proteinopathy→dementia) and the other indirect pathway that includes hippocampal sclerosis pathology (TDP-43 proteinopathy→hippocampal sclerosis→dementia): in the statistical model, the TDP-43 proteinopathy is independently associated with both hippocampal sclerosis pathology and clinical dementia status. Further, the data indicate that a subset of TDP-43 proteinopathy is ‘downstream’ of ADNC-type neuritic amyloid plaque pathology. In a practical sense, this means that brains with more neuritic amyloid plaques are more likely to have TDP-43 proteinopathy, with all other known factors being the same. Aβ = amyloid-β.](https://figures.cochat.ai/paper-figures/9bc83b3adf7f42d5a250b59d9652e7a1/limbic-predominant-age-related-tdp-43-encephalopathy-late-consensus-working-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A consensus group, for example, has described hippocampal sclerosis associated with TDP-43 proteinopathy, as limbic-predominant age-related TDP-43 encephalopathy (LATE) dementia, usually found in people older than 80 years, progressing more slowly than Alzheimer's disease, detectable at post-mortem, often mimicking or comorbid with Alzheimer's disease.3”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“50–60% of Alzheimer’s-type dementia (dementia defined clinically as Alzheimer’s disease) is estimated to be attributable to these copathologies.40,42–45”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LATE is a recently described entity which affects older people and presents with an amnestic picture resembling Alzheimer's disease 178 .”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [178]
The cited source says what the claim attributes to it.
In the citing paper
“Limbic-predominant age-related TDP43 encephalopathy (LATE), defined approximately 3 years ago, is a condition in which typical TDP43 protein inclusions are present with or without coexisting hippocampal sclerosis.29”
From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [29]
The cited source says what the claim attributes to it.
In the citing paper
“The predominant neuropathological change in LATE is TDP-43 proteinopathy, which is associated with a clinical presentation of amnestic dementia that can mimic Alzheimer's dementia.”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [20]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Self-citationAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Self-citationBlessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117 · cited 1×
“LATE-NC is mostly seen in the oldest-old, whereas in early clinical-pathological correlation studies of dementia (Roth et al., 1966; Blessed et al., 1968), the research subjects had died in their early 70s.”
BackgroundAssociation of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059 · cited 1×
“This stratification will enable enrichment for subjects on the ADNC continuum (Sevigny et al., 2016) while excluding subjects likely to have high risk for LATE-NC (Botha et al., 2018).”
BackgroundMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894
Self-citationStages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194 · cited 1×
“seen at autopsy with every year of advanced old age (Braak et al., 2011; Nelson et al., 2011a, 2013; Brenowitz et al., 2014; Neltner et al., 2016).”
BackgroundPorta, M. (2026) · doi:10.1093/acref/9780197663639.001.0001 · Cited by 2,175
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Self-citation
Research works printed but not linked: 3
- Kuslansky G, Verghese J, Dickson D, Katz M, Busche H, Lipton RB Hippocampal sclerosis: cognitive consequences and contribution to dementia. Neurology 2004; 62: A128– 9.
- Porta M. Dictionary of Epidemiology. 6th edn. New York: Oxford University Press; 2014.
- Thom M, Sisodiya S Epilepsy. In: Love S, Perry A, Ironside JW, Budka H, editors. Greenfield’s Neuropathology. New York: CRC Press; 2015 p. 683– 739.
Cited by
Items 601–700 of 1,004
Extracellular chaperone networks and the export of J-domain proteins
Braun, J. E. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102840 · Cited by 17
Pathomechanisms of cognitive impairment in progressive supranuclear palsy
Jellinger, K. A. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02613-w · Cited by 17
Minogue, G., Kawles, A., Zouridakis, A., Keszycki, R. M., Macomber, A. J., Lubbat, V., Gill, N. P., Mao, Q., Flanagan, M. E., Zhang, H., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26762 · Cited by 17
Self-citationWong, P., Ho, W. Y., Yen, Y.-C., Sanford, E., & Ling, S. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.019 · Cited by 17
In vivo cortical diffusion imaging relates to Alzheimer's disease neuropathology
Torso, M., Ridgway, G. R., Valotti, M., Hardingham, I., Chance, S. A., for the National Alzheimer’s Coordinating Center, Brewer, J., Lopez, O., Hyman, B., Grabowski, T., et al. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01309-3 · Cited by 16
Self-citationShort RNA chaperones promote aggregation-resistant TDP-43 conformers to mitigate neurodegeneration
Copley, K. E., Mauna, J. C., Danielson, H. L., Chen, Q., Ozguney, B., Ngo, M., Xie, L., Smirnov, A., Davis, M., Mayne, L., et al. (2026) · Science · doi:10.1126/science.adv3301 · Cited by 16
Tomé, S. O., Gawor, K., Ospitalieri, S., Ronisz, A., Otto, M., Arnim, C. A. F. V., Ghebremedhin, E., Laureyssen, C., Sleegers, K., Vandenberghe, R. R., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02929-9 · Cited by 16
Self-citationAbushakra, S. R., Doraiswamy, P. M., Hey, J. A., Tosun, D., Barkhof, F., Barakos, J. A., Petrella, J. R., Kesslak, J. P., Power, A., Sabbagh, M. N., et al. (2025) · CNS Drugs · doi:10.1007/s40263-025-01251-y · Cited by 16
Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
Rudman, M. D., Ulrich, J. D., & Holtzman, D. M. (2026) · Cell · doi:10.1016/j.cell.2026.06.006 · Cited by 19
Characterization of cerebellar amyloid-β deposits in Alzheimer disease
Lopez, G., Magaki, S., Williams, C. K., Paganini‐Hill, A., & Vinters, H. V. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad107 · Cited by 16
Sexton, C. E., Bitan, G., Bowles, K. R., Bryś, M., Buée, L., Maina, M. B., Clelland, C. D., Cohen, A. D., Crary, J. F., Dage, J. L., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13533 · Cited by 16
Self-citationKon, T., Forrest, S. L., Lee, S., Li, J., Chasiotis, H., Nassir, N., Uddin, M. J., Lang, A. E., & Kovács, G. G. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106551 · Cited by 16
Biophysical characterization of the phase separation of TDP-43 devoid of the C-terminal domain
Staderini, T., Bigi, A., Lagrève, C., Marzi, I., Bemporad, F., & Chiti, F. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00615-4 · Cited by 16
Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism
Takahashi, H., Pérez‐Cañamás, A., Lee, C. W., Ye, H., Han, X., & Strittmatter, S. M. (2024) · Communications Biology · doi:10.1038/s42003-024-06810-5 · Cited by 16
Asken, B. M., Curiel, R. E., Crocco, E., Armstrong, M. J., Levy, S.-A. T., Arias, F., Rosselli, M., Vélez-Uribe, I., Barker, W., Matusz, E. F., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100011 · Cited by 16
Browne, D. F., Smirnov, D. S., Coughlin, D. G., Peng, I., Standke, H. G., Kim, Y., Pizzo, D. P., Unapanta, A., Andreasson, T., Hiniker, A. O., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56469-7 · Cited by 16
The role of endolysosomal progranulin and TMEM106B in neurodegenerative diseases
Takahashi, H., & Strittmatter, S. M. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00873-6 · Cited by 16
Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies
Almeida, F., Marx, G. A., Rohde, S. K., Gonzales, M. M., Maldonado‐Díaz, C., Hiya, S., Clare, K. M., Samanamud, J. L., Slocum, C., Kauffman, J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70575 · Cited by 16
Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention
Eroglu, E., & HARMANCI, N. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70107 · Cited by 16
Buciuc, M., Whitwell, J. L., Boeve, B. F., Ferman, T. J., Graff‐Radford, J., Savica, R., Kantarci, K., Fields, J. A., Knopman, D. S., Petersen, R. C., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09718-2 · Cited by 16
Self-citation3D Reconstruction and Segmentation of Dissection Photographs for MRI-Free Neuropathology
Tregidgo, H. F. J., Casamitjana, A., Latimer, C. S., Kilgore, M. D., Robinson, E., Blackburn, E., Leemput, K. V., Fischl, B. R., Dalca, A. V., Donald, C. M., et al. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-59722-1_20 · Cited by 16
Hausner, L., Frölich, L., Arnim, C. A. F. V., Bohlken, J., Dodel, R. C., Otto, M., Rapp, M. A., Schulz, J. B., Supprian, T., Wollmer, M. A., et al. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-01007-7 · Cited by 16
Phosphorylated TAR DNA-binding protein-43: Aggregation and antibody-based inhibition
Esposto, J., & Martić, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166234 · Cited by 16
Chan, C. K., Pettigrew, C. A., Soldan, A., Zhu, Y., Wang, M., Albert, M., & Rosenberg, P. B. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215267 · Cited by 16
A novel histological staging of hippocampal sclerosis that is evident in gray matter loss in vivo
Ortega‐Cruz, D., Uceda‐Heras, A., Iglesias, J. E., Zea‐Sevilla, M. A., Strange, B. A., & Rábano, A. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12942 · Cited by 16
Plasma TDP‐43 levels are associated with neuroimaging measures of brain structure in limbic regions
Bauer, C. E., Zachariou, V., Sudduth, T. L., Eldik, L. J. V., Jicha, G. A., Nelson, P. T., Wilcock, D. M., & Gold, B. T. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12437 · Cited by 16
Self-citationNadebaum, D. P., Krishnadas, N., Poon, A. M. T., Kalff, V., Lichtenstein, M., Villemagne, V. L., Jones, G. R., & Rowe, C. C. (2020) · Internal Medicine Journal · doi:10.1111/imj.14890 · Cited by 16
Pathological Correlations of Neuropsychiatric Symptoms in Institutionalized People with Dementia
Antonio, E. E., López‐Álvarez, J., Rábano, A., Agüera-Ortíz, L., Sánchez‐Soblechero, A., Amaya, L. J. D., Portela, S., Caramé, C. C., & Olazarán, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200600 · Cited by 16
Buciuc, M., Whitwell, J. L., Baker, M., Rademakers, R., Dickson, D. W., & Josephs, K. A. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12727 · Cited by 16
Self-citationApplication of deep learning to understand resilience to Alzheimer's disease pathology
Lee, C. S., Latimer, C. S., Henriksen, J. C., Blazes, M. S., Larson, E. B., Crane, P. K., Keene, C. D., & Lee, A. (2021) · Brain Pathology · doi:10.1111/bpa.12974 · Cited by 16
Self-citationAssociation between hippocampal microglia, AD and LATE‐NC, and cognitive decline in older adults
Kapasi, A., Yu, L., Leurgans, S. E., Agrawal, S., Boyle, P. A., Bennett, D. A., & Schneider, J. A. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13780 · Cited by 15
Self-citationLavrova, A., Pham, N. T. T., Vernon, C. J., Carlos, A. F., Petersen, R. C., Dickson, D. W., Lowe, V. J., Jack, C. R., Whitwell, J. L., & Josephs, K. A. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12312-5 · Cited by 15
Self-citationYoussef, H., Gatto, R. G., Pham, N. T. T., Petersen, R. C., Machulda, M. M., Reichard, R. R., Dickson, D. W., Jack, C. R., Whitwell, J. L., & Josephs, K. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240136 · Cited by 15
Self-citationCognitive resilience to Alzheimer's disease characterized by cell‐type abundance
O’Neill, N. K., Stein, T. D., Olayinka, O. A., Empawi, J. A., Hu, J., Tong, T., Zhang, X., & Farrer, L. A. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14187 · Cited by 15
Evaluating the updated LATE‐NC staging criteria using data from NACC
Woodworth, D. C., Nguyen, K. M., Sordo, L., Scambray, K. A., Head, E., Kawas, C. H., Corrada, M. M., Nelson, P. T., & Sajjadi, S. A. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14262 · Cited by 15
Self-citationImmune system activation and cognitive impairment in arterial hypertension
Schreiber, S., Arndt, P., Morton, L., Garza, A. P., Müller, P., Neumann, K., Mattern, H., Dörner, M., Bernal, J., Vielhaber, S., et al. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00219.2024 · Cited by 15
Katsumata, Y., Wu, X., Aung, K. Z., Fardo, D. W., Woodworth, D. C., Sajjadi, S. A., Tomé, S. O., Thal, D. R., Troncoso, J. C., Chang, K., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02821-y · Cited by 15
Self-citationHiya, S., Maldonado‐Díaz, C., Rohde, S. K., Gonzales, M. M., Canbeldek, L., Mahadevan, L. S. K., Yokoda, R. T., Sullivan, A. C., Parker, A. S., White, C. L., et al. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae134 · Cited by 15
Xie, L., Das, S. R., Li, Y., Wisse, L. E. M., McGrew, E., Lyu, X., DiCalogero, M., Shah, U., Ilesanmi, A. E., Denning, A. E., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14492 · Cited by 15
Lagarde, J., Maiti, P., Schonhaut, D. R., Blazhenets, G., Zhang, J., Eloyan, A., Thangarajah, M., Taurone, A., Allen, I. E., Soleimani‐Meigooni, D. N., et al. (2025) · Annals of Neurology · doi:10.1002/ana.27233 · Cited by 15
Gao, J., Ding, M., Qin, S., Shukla, D., Vicuna, L., Liang, J., & Wang, X. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03089-8 · Cited by 15
Youssef, H., Weissmann, C., Uruk, G., & Gatto, R. G. (2025) · Brain Sciences · doi:10.3390/brainsci15070716 · Cited by 15
Hunter, S., Hokkanen, S. R. K., Keage, H. A. D., Fleming, J., Minett, T., Polvikoski, T. M., Allinson, K. S. J., & Brayne, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191093 · Cited by 15
Self-citationGicas, K. M., Honer, W. G., Wilson, R. S., Boyle, P. A., Leurgans, S. E., Schneider, J. A., & Bennett, D. A. (2020) · Neurology · doi:10.1212/wnl.0000000000010952 · Cited by 15
Self-citationKlotz, S., Fischer, P. A., Hinterberger, M., Ricken, G., Hönigschnabl, S., Gelpí, E., & Kovács, G. G. (2020) · Neuropathology · doi:10.1111/neup.12708 · Cited by 15
Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration
Sieben, A., Langenhove, T. V., Vermeiren, Y., Gossye, H., Praet, M. M., Vanhauwaert, D. J., Cousaert, C., Engelborghs, S., Raedt, R., Boon, P., et al. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab010 · Cited by 15
Cerebrovascular disease in suspected non‐Alzheimer's pathophysiology and cognitive decline over time
Saridin, F. N., Chew, K. A., Reilhac, A., Gyanwali, B., Villaraza, S. G., Tanaka, T., Scheltens, P., van der Flier, W. M., Chen, C., & Hilal, S. (2022) · European Journal of Neurology · doi:10.1111/ene.15337 · Cited by 15
Neuropathology and cholinesterase expression in the brains of octogenarians and older
Maxwell, S. P., Cash, M. K., & Darvesh, S. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110065 · Cited by 15
Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies
Coughlin, D. G., Hiniker, A. O., Peterson, C. S., Kim, Y., Arezoumandan, S., Giannini, L., Pizzo, D. P., Weintraub, D. A., Siderowf, A. D., Litvan, I., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac094 · Cited by 15
Self-citationAssociation of Stroke and Cerebrovascular Pathologies With Scam Susceptibility in Older Adults
Kapasi, A., Schneider, J. A., Yu, L., Lamar, M., Bennett, D. A., & Boyle, P. A. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.3711 · Cited by 15
Self-citationLoss of TMEM106B exacerbates C9ALS/FTD DPR pathology by disrupting autophagosome maturation
Bauer, C. S., Webster, C. P., Shaw, A. C., Kok, J. R., Castelli, L. M., Lin, Y.-H., Smith, E. F., Illanes-Álvarez, F., Higginbottom, A., Shaw, P. J., et al. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1061559 · Cited by 15
The frequency and distribution of TDP-43 pathology in argyrophilic grain disease
Koga, S., Murakami, A., Martin, N. B., & Dickson, D. W. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad042 · Cited by 15
Self-citationNeuropathologic Changes of Alzheimer’s Disease and Related Dementias: Relevance to Future Prevention
White, L. R., Corrada, M. M., Kawas, C. H., Cholerton, B., Edland, S. E., Flanagan, M. E., & Montine, T. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230331 · Cited by 16
Self-citationEffective Inhibition of TDP‐43 Aggregation by Native State Stabilization
Yang, L., Jasiqi, Y., Zettor, A., Vadas, O., Chiaravalli, J., Agou, F., & Lashuel, H. A. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202314587 · Cited by 15
Wuestefeld, A., Baumeister, H., Adams, J. N., de Florès, R., Hodgetts, C. J., Mazloum‐Farzaghi, N., Olsen, R. K., Puliyadi, V., Tran, T., Bakker, A., et al. (2024) · Hippocampus · doi:10.1002/hipo.23602 · Cited by 15
Vanderstichele, H., Teunissen, C. E., & Vanmechelen, E. (2019) · Neurology and Therapy · doi:10.1007/s40120-019-00166-3 · Cited by 15
Brain TDP‐43 pathology in corticobasal degeneration: Topographical correlation with neuronal loss
Sainouchi, M., Tada, M., Fitrah, Y. A., Hara, N., Tanaka, K., Idezuka, J., Aida, I., Nakajima, T., Miyashita, A., Akazawa, K., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12786 · Cited by 15
Association of Hippocampal Subfield Volumes with Amyloid-Beta Deposition in Alzheimer’s Disease
Baek, M. S., Lee, N., Kim, J. W., & Hong, J. Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061526 · Cited by 15
Mesa-Herrera, F., Marín, R., Torrealba, E., Santos, G., & Díaz, M. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.879146 · Cited by 15
Acetylation of lysine 82 initiates TDP-43 nuclear loss of function by disrupting its nuclear importPreprint
Zhang, S., Vazquez‐Sanchez, S., Lu, S., Baughn, M. W., Lim, J., Oung, S., Gao, L., Diedrich, J. K., Yates, J. R., Yu, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.04.611121 · Cited by 15
Yokota, O., Miki, T., Nakashima‐Yasuda, H., Ishizu, H., Haraguchi, T., Ikeda, C., Miyashita, A., Ikeuchi, T., Takenoshita, S., Terada, S., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01643-5 · Cited by 14
Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE
Alexander, A. L., Alvarez, V. E., Huber, B. R., Alosco, M. L., Mez, J., Tripodis, Y., Nicks, R., Katz, D. I., Dwyer, B. C., Daneshvar, D. H., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02690-5 · Cited by 14
Ho, S., Hsiao, I., Lin, K., Wu, Y., & Wu, K. (2024) · Brain and Behavior · doi:10.1002/brb3.70016 · Cited by 14
Bentivenga, G. M., Baiardi, S., Mastrangelo, A., Ruggeri, E., Mammana, A., Ticca, A., Rossi, M., Capellari, S., & Parchi, P. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01565-x · Cited by 14
Burgueño‐García, I., López-Martínez, M. J., Uceda‐Heras, A., García‐Carracedo, L., Zea‐Sevilla, M. A., Rodrigo-Lara, H., Rego-García, I., Saiz-Aúz, L., Ruiz-Valderrey, P., López‐González, F. J., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226755 · Cited by 14
Athalye, C., Bahena, A., Khandelwal, P., Emrani, S., Trotman, W., Levorse, L. M., Khodakarami, Z., Ohm, D. T., Teunissen‐Bermeo, E., Capp, N., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02030-y · Cited by 14
Mild cognitive impairment: To diagnose or not to diagnose
Wang, K., Page, A. T., & Etherton‐Beer, C. (2021) · Australian Journal on Ageing · doi:10.1111/ajag.12913 · Cited by 14
Hokelekli, F. O., Whitwell, J. L., Machulda, M. M., Jones, D. T., Uitti, R. J., Pham, N. T. T., Giannini, C., Baker, M., Lowe, V. J., Dickson, D. W., et al. (2021) · Neurocase · doi:10.1080/13554794.2021.1918723 · Cited by 14
Self-citationJusto‐Henriques, S. I., Pérez, E., Apóstolo, J., & Carvalho, J. O. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225395 · Cited by 14
Dominguez, J. C., Yu, J. R. T., Guzman, M. F. D., Ampil, E. R., Guevarra, A. C., Joson, M. L. C., Reandelar, M., Martinez, M., Ligsay, A. D., Ocampo, F. F., et al. (2022) · International Journal of Alzheimer s Disease · doi:10.1155/2022/9960832 · Cited by 14
Prediction of neuropathologic lesions from clinical data
Phongpreecha, T., Cholerton, B., Bukhari, S. A., Chang, A. L., Francesco, D. D., Thuraiappah, M., Godrich, D., Perna, A., Becker, M., Ravindra, N. G., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12921 · Cited by 14
Self-citationMRI in the new era of antiamyloid mAbs for the treatment of Alzheimer's disease
Filippi, M., Cecchetti, G., & Agosta, F. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001177 · Cited by 14
Transactive response DNA-binding protein 43 is enriched at the centrosome in human cells
Bodin, A., Greibill, L., Gouju, J., Letournel, F., Pozzi, S., Julien, J., Renaud, L., Bohl, D., Millecamps, S., Verny, C., et al. (2023) · Brain · doi:10.1093/brain/awad228 · Cited by 14
Leiby, A. C., Scambray, K. A., Nguyen, H. L., Basith, F., Fakhraee, S., Melikyan, Z. A., Bukhari, S. A., Montine, T. J., Corrada, M. M., Kawas, C. H., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230238 · Cited by 14
Self-citationLangroudi, S. R. F., Zeinaly, M., & Ajamian, F. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00385-1 · Cited by 14
Garamszegi, S. P., Brzostowicki, D. J., Coyne, T. M., Vontell, R., & Davis, D. A. (2024) · Toxins · doi:10.3390/toxins16010042 · Cited by 14
Mol, M. O., Nijmeijer, S. W. R., van Rooij, J., van Spaendonk, R. M. L., Pijnenburg, Y. A. L., van der Lee, S. J., van Minkelen, R., Kaat, L. D., Rozemüller, A. J. M., van Mantgem, M. R. J., et al. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325150 · Cited by 14
An autopsy case of pure nigropathy with TUBA4A nonsense mutation
Okada, K., Hata, Y., Ichimata, S., Yoshida, K., Oku, Y., Asahi, T., & Nishida, N. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12712 · Cited by 14
Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis
Forrest, S. L., Kim, J. H., Sousa, C. D., Cheong, R., Crockford, D. R., Sheedy, D. L., Stevens, J., McCrossin, T., Tan, R. H., McCann, H., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14849 · Cited by 14
Self-citationLaurents, D. V., Stuani, C., Pantoja‐Uceda, D., Buratti, E., & Mompeán, M. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.09.040 · Cited by 14
Tau seeding in chronic traumatic encephalopathy parallels disease severity
Kaufman, S. K., Svirsky, S. E., Cherry, J. D., McKee, A. C., & Diamond, M. I. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02373-5 · Cited by 14
Hamilton, C. A., Matthews, F. E., Erskine, D., Attems, J., & Thomas, A. J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01301-8 · Cited by 14
Self-citationBaiardi, S., Mammana, A., Rossi, M., Ladogana, A., Carlà, B., Gambetti, P. L., Capellari, S., & Parchi, P. (2022) · Viruses · doi:10.3390/v14020367 · Cited by 14
The Social Construction of Dementia
Wray, A. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190917807.003.0004 · Cited by 14
Theoretical impact of the AT(N) framework on dementia using a community autopsy sample
Burke, B. T., Latimer, C., Keene, C. D., Sonnen, J. A., McCormick, W., Bowen, J. D., McCurry, S. M., Larson, E. B., & Crane, P. K. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12348 · Cited by 13
Self-citationPiccolo, L. L., Umegawachi, T., Yeewa, R., Potikanond, S., Nimlamool, W., Prachayasittikul, V., Gotoh, Y., Yoshida, H., Yamaguchi, M., & Jantrapirom, S. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01406-z · Cited by 13
Javierre‐Petit, C., Kontzialis, M. S., Leurgans, S. E., Bennett, D. A., Schneider, J. A., & Arfanakis, K. (2024) · Brain Communications · doi:10.1093/braincomms/fcae252 · Cited by 13
Self-citationGenetics and Neuropathology of Neurodegenerative Dementias
Scholz, S. W., & Cobos, I. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001505 · Cited by 13
Lavrova, A., Pham, N. T. T., Reid, R. I., Boeve, B. F., Knopman, D. S., Petersen, R. C., Nguyen, A. T., Reichard, R. R., Dickson, D. W., Jack, C. R., et al. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.03.001 · Cited by 13
Self-citationChallenges of modelling TDP-43 pathology in mice
Armas, J. M. B., Taoro‐González, L., Fisher, E., & Acevedo‐Arozena, A. (2025) · Mammalian Genome · doi:10.1007/s00335-025-10131-1 · Cited by 13
Unlocking the cellular mystery: how proton pump inhibitors may alter the dementia landscape
Mohan, M., Mannan, A., Singh, S., & Singh, T. G. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149702 · Cited by 13
Bonetto, V., Ferraresi, A., Sampò, S., & Isidoro, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104800 · Cited by 13
Rates of clinical progression according to biological Alzheimer's disease stages
Trudel, L., Therriault, J., Macedo, A. C., Servaes, S., Hosseini, S. A., Bezgin, G., Rahmouni, N., Chan, T., Arias, J. F., Aumont, É., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70624 · Cited by 13
Kivisäkk, P., Fatima, H. A., Wu, C., Padmanabhan, N., Romero, D., Gorham, T., Weik, M., Dodge, H. H., Scherzer, C. R., Das, S., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214351 · Cited by 13
Huang, W., Huang, J., Kuang, N., Wu, J., Feng, F., Luo, Y., & Huang, N. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103290 · Cited by 13
Fletcher, J. R. (2020) · Sociology of Health & Illness · doi:10.1111/1467-9566.13054 · Cited by 13
α-synuclein as an emerging pathophysiological biomarker of Alzheimer’s disease
Beatino, M. F., Luca, C. D., Campese, N., Belli, E., Piccarducci, R., Giampietri, L., Martini, C., Perugi, G., Siciliano, G., Ceravolo, R., et al. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2068952 · Cited by 13
Tamsen, F., & Alafuzoff, I. I. (2022) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-022-03462-w · Cited by 13
Self-citationAAV-GRN partially corrects motor deficits and ALS/FTLD-related pathology in Tmem106b−/−Grn−/− mice
Feng, T., Minevich, G., Liu, P., Qin, H. X., Wozniak, G. G., Pham, J., Pham, K., Korgaonkar, A. A., Kurnellas, M., Defranoux, N. A., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107247 · Cited by 13
Boon, B. D. C., Labuzan, S. A., Peng, Z., Matchett, B. J., Kouri, N., Hinkle, K. M., Lachner, C., Ross, O. A., Ertekin‐Taner, N., Carter, R. E., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207685 · Cited by 13
Self-citation
Metadata
- Authors
- Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I., Attems, J., Brayne, C., Coyle-Gilchrist, I. T. S., Chui, H. C., Fardo, D. W., Flanagan, M. E., Halliday, G., Hokkanen, S. R. K., Hunter, S., Jicha, G. A., Katsumata, Y., Kawas, C. H., Keene, C. D., Kovacs, G. G., Kukull, W. A., Levey, A. I., Makkinejad, N., Montine, T. J., Murayama, S., Murray, M. E., Nag, S., Rissman, R. A., Seeley, W. W., Sperling, R. A., White III, C. L., Yu, L., & Schneider, J. A.
- Affiliations
- University of Kentucky (US)
- Mayo Clinic in Florida (US)
- University of Pennsylvania (US)
- Mayo Clinic (US)
- Rush University Medical Center (US)
- Uppsala University (SE)
- Newcastle University (GB)
- University of Cambridge (GB)
- University of Southern California (US)
- University of Minnesota (US)
- The University of Sydney (AU)
- University of California, Irvine (US)
- University of Washington (US)
- Institute of Neurology Medical University of Vienna, Vienna, Austria
- Emory University (US)
- Illinois Institute of Technology (US)
- Stanford University (US)
- Tokyo Metropolitan Institute of Gerontology (JP)
- University of California San Diego (US)
- University of California, San Francisco (US)
- Harvard University (US)
- University of Texas Southwestern Medical Center, Dallas, TX, USA
- Corresponding author
- Nelson, Peter T
- ORCID
- Nelson, Peter T
- Dickson, Dennis W
- Trojanowski, John Q
- Jack, Clifford R
- Boyle, Patricia A
- Arfanakis, Konstantinos
- Rademakers, Rosa
- Alafuzoff, Irina
- Attems, Johannes
- Brayne, Carol
- Coyle-Gilchrist, Ian T S
- Chui, Helena C
- Fardo, David W
- Flanagan, Margaret E
- Halliday, Glenda
- Hokkanen, Suvi R K
- Hunter, Sally
- Jicha, Gregory A
- Katsumata, Yuriko
- Kawas, Claudia H
- Keene, C Dirk
- Kukull, Walter A
- Levey, Allan I
- Makkinejad, Nazanin
- Montine, Thomas J
- Murayama, Shigeo
- Murray, Melissa E
- Nag, Sukriti
- Rissman, Robert A
- Seeley, William W
- Sperling, Reisa A
- Yu, Lei
- Schneider, Julie A
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-04-30
- Volume
- 142
- Issue
- 6
- Pages
- 1503-1527
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6536849
- OpenAlex
- W2943828894
- Cited by
- 1,547
- References
- 276
- Citations by year
- 2026: 206 · 2025: 240 · 2024: 211 · 2023: 214 · 2022: 213 · 2021: 193 · 2020: 198 · 2019: 66
- FWCI
- 113.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by-nc)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
- Apollo
- Funders
- NIA
- NACC
- NIH (U01 AG016976)
- National Health and Medical Research Council
- NHMRC (1132524, 1095127, 1037746)
- Senior Principal Research Fellowship (1079679)
- National Institutes of Health (P01 AG003949, R01 AG037491, P50 AG016574, R01 AG054449, P30 AG028303, P30 AG012300, P30 AG049638, P30 AG010124, P30 AG010161, P50 AG047366, P50 AG025688, P50 AG005131, R37 AG011378, R01 AG041851, R01 AG042210, R01 AG017917, R01 AG034374, UF1 AG053983, UF1 AG057707)
- NIHR (534906, NF-SI-0616–10090)
- National Institute for Health Research
- NHS
- Department of Health and Social Care
- Addenbrooke’s Charitable Trust
- Paul G. Allen Family Foundation and Alzheimer’s Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- limbic-predominant age-related TDP-43 encephalopathy, TDP-43 proteinopathy, hippocampal sclerosis, diagnostic criteria, neuropathological staging, amygdala, medial temporal lobe atrophy, genetic risk variants, gene regulatory networks, TMEM106B, ABCC9, apolipoprotein E, Alzheimer's disease, frontotemporal lobar degeneration
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Brain Diseases, Female, Humans, Male, Middle Aged, Retrospective Studies, Frontotemporal Lobar Degeneration, TDP-43 Proteinopathies, Frontotemporal Dementia, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.